Product Code: ETC340805 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Argentina pneumonia vaccine market is experiencing growth, driven by public health initiatives and immunization programs aimed at preventing pneumonia and related respiratory infections. Pneumonia vaccines, including pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV), protect against bacterial and viral pathogens causing pneumonia, reducing disease burden and healthcare costs in Argentina.
The Argentina Pneumonia Vaccine market is experiencing robust growth driven by the increasing prevalence of pneumonia, respiratory infections, and vaccine-preventable diseases, particularly among children, elderly, and immunocompromised populations. Pneumonia vaccines, including pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV), provide protection against bacterial pathogens such as Streptococcus pneumoniae, a common cause of pneumonia and invasive pneumococcal disease. With the emphasis on immunization programs, public health initiatives, and disease prevention strategies, there is growing demand for pneumonia vaccines to reduce morbidity, mortality, and healthcare costs associated with respiratory infections. Moreover, investments in vaccine research, development, and distribution infrastructure are driving market expansion in the pneumonia vaccine sector.
The pneumonia vaccine market in Argentina faces challenges related to healthcare access, vaccination coverage, and market dynamics. While pneumonia vaccines offer essential protection against respiratory infections, ensuring equitable distribution and affordability pose challenges for healthcare authorities. Moreover, addressing vaccine hesitancy and misinformation impacts vaccination rates and herd immunity levels. Additionally, navigating procurement processes and negotiating pricing agreements with vaccine manufacturers can be complex for healthcare agencies. Furthermore, fostering public-private partnerships and investing in vaccination campaigns are essential for overcoming challenges and improving vaccine coverage in Argentina.
Argentina healthcare policies prioritize vaccination programs to prevent and control infectious diseases such as pneumonia. Government initiatives may include vaccination schedules, immunization campaigns, and public health education efforts to increase vaccine coverage and reduce the burden of pneumonia in the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Pneumonia Vaccine Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Argentina Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Argentina Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Argentina Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Argentina Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.8 Argentina Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Argentina Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing pneumonia |
4.2.2 Rising government initiatives to improve vaccination coverage in Argentina |
4.2.3 Growing geriatric population in Argentina, who are more susceptible to pneumonia |
4.3 Market Restraints |
4.3.1 High cost of pneumonia vaccines leading to affordability issues for certain population segments |
4.3.2 Limited access to healthcare facilities in remote areas, impacting vaccine distribution and administration |
5 Argentina Pneumonia Vaccine Market Trends |
6 Argentina Pneumonia Vaccine Market, By Types |
6.1 Argentina Pneumonia Vaccine Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Pneumonia Vaccine Market Revenues & Volume, By Vaccine Type, 2021-2031F |
6.1.3 Argentina Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021-2031F |
6.1.4 Argentina Pneumonia Vaccine Market Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021-2031F |
6.2 Argentina Pneumonia Vaccine Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina Pneumonia Vaccine Market Revenues & Volume, By Prevnar 13, 2021-2031F |
6.2.3 Argentina Pneumonia Vaccine Market Revenues & Volume, By Synflorix, 2021-2031F |
6.2.4 Argentina Pneumonia Vaccine Market Revenues & Volume, By Pneumovax 23, 2021-2031F |
6.3 Argentina Pneumonia Vaccine Market, By Sector |
6.3.1 Overview and Analysis |
6.3.2 Argentina Pneumonia Vaccine Market Revenues & Volume, By Public, 2021-2031F |
6.3.3 Argentina Pneumonia Vaccine Market Revenues & Volume, By Private, 2021-2031F |
6.4 Argentina Pneumonia Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Argentina Pneumonia Vaccine Market Revenues & Volume, By Distribution Partner Companies, 2021-2031F |
6.4.3 Argentina Pneumonia Vaccine Market Revenues & Volume, By Non-governmental Organizations (NGO), 2021-2031F |
6.4.4 Argentina Pneumonia Vaccine Market Revenues & Volume, By Government Authorities, 2021-2031F |
7 Argentina Pneumonia Vaccine Market Import-Export Trade Statistics |
7.1 Argentina Pneumonia Vaccine Market Export to Major Countries |
7.2 Argentina Pneumonia Vaccine Market Imports from Major Countries |
8 Argentina Pneumonia Vaccine Market Key Performance Indicators |
8.1 Vaccination coverage rate among high-risk populations (e.g., elderly, children) |
8.2 Number of government vaccination campaigns conducted annually |
8.3 Percentage of healthcare facilities equipped to administer pneumonia vaccines |
9 Argentina Pneumonia Vaccine Market - Opportunity Assessment |
9.1 Argentina Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Argentina Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Argentina Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
9.4 Argentina Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Argentina Pneumonia Vaccine Market - Competitive Landscape |
10.1 Argentina Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Argentina Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |